Merck KGaA Ties Up Chord To Advance Cladribine Rare Disease Programs

Acquires Swiss Biotech To Expand Neurology Pipeline

 
• By Kevin Grogan
  
merck kgaa
The Darmstadt-based group is looking for bolt-ons • Source: Merck KGaA
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Business